$1.6 Billion is the total value of Third Security, LLC's 22 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 10.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XON | INTREXON CORP | $1,161,333,000 | -26.1% | 62,504,446 | 0.0% | 72.45% | -3.2% | |
| HALO | HALOZYME THERAPEUTICS INC | $180,327,000 | -7.9% | 19,816,162 | 0.0% | 11.25% | +20.6% | |
| ZIOP | ZIOPHARM ONCOLOGY INC | $47,033,000 | -34.5% | 17,815,708 | 0.0% | 2.93% | -14.2% | |
| FCSC | FIBROCELL SCIENCE INC | $45,369,000 | -27.3% | 15,644,427 | 0.0% | 2.83% | -4.8% | |
| EPD | Buy | ENTERPRISE PRODS PARTNERS L | $36,070,000 | +3.0% | 895,034 | +100.0% | 2.25% | +34.8% |
| PAA | PLAINS ALL AMERN PIPELINE Lunit ltd partn | $23,544,000 | -2.0% | 400,000 | 0.0% | 1.47% | +28.4% | |
| ET | ENERGY TRANSFER EQUITY L P | $23,208,000 | +4.7% | 376,200 | 0.0% | 1.45% | +37.1% | |
| SYN | SYNTHETIC BIOLOGICS INC | $21,896,000 | +3.5% | 12,300,768 | 0.0% | 1.37% | +35.5% | |
| OGEN | ORAGENICS INC | $12,299,000 | -35.9% | 9,839,221 | 0.0% | 0.77% | -16.1% | |
| GEL | GENESIS ENERGY L Punit ltd partn | $11,423,000 | -6.1% | 217,000 | 0.0% | 0.71% | +23.1% | |
| NS | NUSTAR ENERGY LP | $7,682,000 | +6.3% | 116,500 | 0.0% | 0.48% | +39.2% | |
| TCP | TC PIPELINES LP | $6,568,000 | +31.1% | 97,000 | 0.0% | 0.41% | +71.5% | |
| CMLP | CRESTWOOD MIDSTREAM PARTNERSunit ltd partner | $6,452,000 | +2.7% | 284,620 | 0.0% | 0.40% | +34.4% | |
| OVAS | OVASCIENCE INC | $6,196,000 | +81.1% | 373,224 | 0.0% | 0.39% | +137.4% | |
| RGP | REGENCY ENERGY PARTNERS L P | $5,407,000 | +1.3% | 165,750 | 0.0% | 0.34% | +32.7% | |
| MMLP | MARTIN MIDSTREAM PRTNRS L Punit l p int | $5,288,000 | -9.4% | 141,800 | 0.0% | 0.33% | +18.7% | |
| TBIO | TRANSGENOMIC INC | $2,905,000 | +0.8% | 770,490 | 0.0% | 0.18% | +32.1% | |
| CDXS | Exit | CODEXIS INC | $0 | – | -1,674,699 | -100.0% | -0.12% | – |
| 4945SC | Exit | KINDER MORGAN ENERGY PARTNERut ltd partner | $0 | – | -318,098 | -100.0% | -1.25% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-11-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HALOZYME THERAPEUTICS INC | 36 | Q1 2022 | 37.6% |
| TC PIPELINES LP | 30 | Q3 2020 | 1.1% |
| ENTERPRISE PRODS PARTNERS L | 29 | Q2 2020 | 6.7% |
| ENERGY TRANSFER LP | 29 | Q2 2020 | 2.7% |
| NUSTAR ENERGY LP | 29 | Q2 2020 | 1.3% |
| INTREXON CORP | 26 | Q4 2019 | 82.5% |
| ZIOPHARM ONCOLOGY INC | 25 | Q2 2020 | 7.5% |
| AQUABOUNTY TECHNOLOGIES INC | 23 | Q3 2022 | 16.9% |
| SYNTHETIC BIOLOGICS INC | 21 | Q2 2018 | 4.0% |
| ORAGENICS INC | 19 | Q4 2017 | 3.9% |
View Third Security, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2022-11-14 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-07-28 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-10 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
View Third Security, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.